AIM
BIIB icon

Axiom Investment Management’s Biogen BIIB Stock Holding History

Axiom Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-796
Closed -$240K – 437
2018
Q4 		$240K Buy
+796
New +$254K 0.05% 302

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axiom Investment Management's BIIB Position: Q1 2019 in Review

Axiom Investment Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 796 shares — an estimated $240K sold.

Axiom Investment Management first reported a position in BIIB in Q4 2018 and held it in 1 quarter. The position peaked at $240K in Q4 2018. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Axiom Investment Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Axiom Investment Management sold 796 Biogen shares in Q1 2019, an estimated $240K.
  • Axiom Investment Management first reported a position in Biogen in Q4 2018 and held it in 1 quarter.
  • Axiom Investment Management's Biogen position peaked at $240K in Q4 2018.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Axiom Investment Management's 13F filing for Q1 2019, filed 16 Mar 2021.